Patent · US Active

Macrolides

US7524823B2 · kind B2 · utility

3Cited by
0References
15Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMay 8, 2006
Grant dateApr 28, 2009
Priority date
Expiry dateMay 2, 2027

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P43/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates to new antibiotic macrolide compounds of the general formula I:with improved activity, to medicaments comprising such antibiotics, and to the use of such antibiotics for the treatment of infectious diseases, inflammatory diseases and human diseases or disorders which can be ameliorated by inhibition human phospdiesterases.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.